Related Experiment Videos

Glycated hemoglobin as a marker of cardiovascular risk

Kay-Tee Khaw1, Nicholas Wareham

  • 1School of Clinical Medicine, University of Cambridge, UK. kk101@medschl.cam.ac.uk

Current Opinion in Lipidology
|November 11, 2006
PubMed

Insights

Glycated hemoglobin predicts cardiovascular disease risk in both diabetic and non-diabetic individuals. Higher levels indicate increased risk, suggesting its utility for targeted interventions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular disease (CVD).
  • Glycated hemoglobin (HbA1c) reflects long-term blood glucose control.
  • Assessing HbA1c aids in CVD risk stratification.

Purpose of the Study:

  • To review the role of glycated hemoglobin in predicting cardiovascular disease risk.
  • To evaluate HbA1c's predictive value in diabetic and non-diabetic populations.

Main Methods:

  • Literature review of studies examining glycated hemoglobin and cardiovascular disease.
  • Analysis of trial data on blood glucose control and CVD reduction.
  • Examination of the relationship between HbA1c levels and CVD risk across the normal distribution.

Main Results:

  • Glycated hemoglobin predicts CVD risk in individuals with diabetes.
  • Good blood glucose control is linked to reduced CVD.
  • Elevated HbA1c levels, even below diabetic thresholds, are associated with increased CVD risk independently of other factors.
  • A 1% increase in HbA1c correlates with a 10-20% rise in CVD risk.
  • This continuous relationship is most pronounced for coronary heart disease in men.

Conclusions:

  • Glycated hemoglobin is a valuable predictor of cardiovascular risk in both diabetic patients and the general population.
  • HbA1c can identify individuals at higher risk for targeted interventions like blood pressure and cholesterol management.
  • Further understanding of the HbA1c-CVD relationship may lead to novel preventive and therapeutic strategies.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...